NVET Key Statistics, Chart & Performance
The current stock price of NVET is 6.72 null. In the past month the price increased by 0.75%. In the past year, price increased by 27.03%.
About NVET
Company Profile
NexvetBiopharma plc is a biopharmaceutical company. The company is focused on transforming the therapeutic market for companion animals by developing and commercializing novel biologic therapies. Its product candidate consists of NV-01, is a mAb for the control of pain associated with osteoarthritis in dogs, NV-02, is a mAb for the control of pain associated with degenerative joint disease in cats and NV-08, is a receptor fusion protein for the treatment of chronic inflammatory diseases. NexvetBiopharma plc is headquartered in Blackrock, Ireland.
Company Info
Nexvet Biopharma Plc
UNIT 5 SRAGH TECHNOLOGY PARK RAHAN ROAD
TULLAMORE L2 R35 FR98
CEO: Mark Heffernan
Phone: 353-57-932-4522
Nexvet Biopharma Plc / NVET FAQ
What does NVET do?
NexvetBiopharma plc is a biopharmaceutical company. The company is focused on transforming the therapeutic market for companion animals by developing and commercializing novel biologic therapies. Its product candidate consists of NV-01, is a mAb for the control of pain associated with osteoarthritis in dogs, NV-02, is a mAb for the control of pain associated with degenerative joint disease in cats and NV-08, is a receptor fusion protein for the treatment of chronic inflammatory diseases. NexvetBiopharma plc is headquartered in Blackrock, Ireland.
What is the stock price of Nexvet Biopharma Plc today?
The current stock price of NVET is 6.72 null.
Does NVET stock pay dividends?
NVET does not pay a dividend.
What is the ChartMill rating of Nexvet Biopharma Plc stock?
NVET has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is Nexvet Biopharma Plc worth?
Nexvet Biopharma Plc (NVET) has a market capitalization of 80.10M null. This makes NVET a Micro Cap stock.
NVET Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NVET. When comparing the yearly performance of all stocks, NVET is one of the better performing stocks in the market, outperforming 76.91% of all stocks.
NVET Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NVET. NVET has a great financial health rating, but its profitability evaluates not so good.
NVET Financial Highlights
Over the last trailing twelve months NVET reported a non-GAAP Earnings per Share(EPS) of -1.75. The EPS decreased by -4.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.17% | ||
| ROA | -63.8% | ||
| ROE | -72.73% | ||
| Debt/Equity | 0 |